This study showcases a vendor-neutral in-silico fragmentation workflow that automates peptide MS/MS interpretation. By applying advanced fragmentation rules, it improves fragment assignment accuracy, enables structural visualization, distinguishes isomers, and streamlines reporting—centralizing data processing across multiple instrument platforms.